# PROTAGONIST THERAPEUTICS, INC. (PTGX) FY2026 Q2 Balance Sheet

- Company: PROTAGONIST THERAPEUTICS, INC. (PTGX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001104659-26-091123
- Page: https://plicit.ai/financials/ptgx/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/ptgx-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 885,544,000 US dollars
- **Current assets**: 807,148,000 US dollars
- **Non-current assets**: 78,396,000 US dollars
- **Liabilities**: 44,001,000 US dollars
- **Current liabilities**: 37,181,000 US dollars
- **Non-current liabilities**: 6,820,000 US dollars
- **Equity**: 841,543,000 US dollars
- **Cash and cash equivalents**: 420,078,000 US dollars
- **Marketable securities**: 362,498,000 US dollars
- **Receivable from collaboration partner**: 13,416,000 US dollars
- **Prepaid expenses and other current assets**: 7,790,000 US dollars
- **Contract asset**: 3,366,000 US dollars
- **Marketable securities - noncurrent**: 66,875,000 US dollars
- **Operating lease right-of-use asset**: 6,946,000 US dollars
- **Property and equipment, net**: 3,456,000 US dollars
- **Other non-current assets**: 832,000 US dollars
- **Restricted cash - noncurrent**: 287,000 US dollars
- **Accrued expenses and other payables**: 21,667,000 US dollars
- **Deferred revenue**: 9,659,000 US dollars
- **Accounts payable**: 3,459,000 US dollars
- **Operating lease liability**: 2,396,000 US dollars
- **Operating lease liability - noncurrent**: 6,820,000 US dollars
- **Additional paid-in capital**: 1,146,409,000 US dollars
- **Common stock, $0.00001 par value, 180,000,000 shares authorized; 64,672,032 and 62,577,897 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively**: 1,000 US dollars
- **Accumulated deficit**: negative 304,039,000 US dollars
- **Accumulated other comprehensive (loss) income**: negative 828,000 US dollars
- **Gross equity (calculated)**: 1,146,410,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
